US Patent No. 9,187,516

Compositions and methods for inhibiting expression of a gene from the Ebola virus
Nov 20, 2015

Alnylam Pharmaceuticals and the US Army have been awarded US Patent No. 9,187,516, "Compositions and methods for inhibiting expression of a gene from the Ebola virus."